301 filings
Page 5 of 16
4
f6k5oq70yzv7k
7 Dec 22
Aridis Pharmaceuticals / FRED KURLAND ownership change
8:59am
4
lj6o3 9e86y
7 Dec 22
Aridis Pharmaceuticals / JOHN F HAMILTON ownership change
8:58am
4
b29fnkt4bt 4zzbxvdm
7 Dec 22
Aridis Pharmaceuticals / Susan Richards Windham-Bannister ownership change
8:57am
S-8
zf3hbse fw33rqc
5 Dec 22
Registration of securities for employees
8:23pm
8-K
lpsmgv7gz2fatqjb
21 Nov 22
Aridis Pharmaceuticals Announces Third Quarter 2022 Financial Results
8:34pm
NT 10-Q
zrj21iau
14 Nov 22
Notice of late quarterly filing
8:56pm
D
umreq
12 Oct 22
$8.00 mm in equity / options / securities to be acquired, sold $8.00 mm, 1 investor
4:15pm
424B5
4bc 2plpjesh
6 Oct 22
Prospectus supplement for primary offering
4:51pm
8-K
pq9gfzxtno
5 Oct 22
Entry into a Material Definitive Agreement
8:01am
8-K
dnqk0csoiteq in1
5 Oct 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:00am
424B5
h9vt e31nhatuu4zpzla
26 Sep 22
Prospectus supplement for primary offering
2:43pm
EFFECT
1x0c2 4fm
13 Sep 22
Notice of effectiveness
12:15am
CORRESP
7pkj8yd
8 Sep 22
Correspondence with SEC
12:00am
UPLOAD
qcx1tfz wt
8 Sep 22
Letter from SEC
12:00am
8-K
jyt kdyabn
16 Aug 22
Aridis Pharmaceuticals Announces Second Quarter 2022 Financial Results and Business Update
4:47pm
NT 10-Q
gd33 1613d
15 Aug 22
Notice of late quarterly filing
9:36pm
8-K
pi2zul3e4g3bx dbt7
15 Aug 22
Other Events
5:49pm